Elafibranor interrupts adipose dysfunction-mediated gut and liver injury in mice with alcoholic steatohepatitis

Author:

Li Tzu-Hao1234,Yang Ying-Ying5623ORCID,Huang Chia-Chang623,Liu Chih-Wei123,Tsai Hung-Cheng1673,Lin Ming-Wei83,Tsai Chang-Youh173,Huang Shiang-Fen923,Wang Ying-Wen573,Lee Tzung-Yan310ORCID,Huang Yi-Hsiang5723,Hou Ming-Chih573,Lin Han-Chieh573

Affiliation:

1. Division of Allergy and Immunology, Taipei Veterans General Hospital, Taipei, Taiwan

2. Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan

3. Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan

4. Division of Allergy and Immunology, Department of Medicine, Chiayi Branch, Taichung Veterans General Hospital, Chiayi, Taiwan

5. Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital, Taipei, Taiwan

6. Division of General Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

7. Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

8. Institute of Public Health, National Yang-Ming University School of Medicine, Taipei, Taiwan

9. Division of Infection, Taipei Veterans General Hospital, Taipei, Taiwan

10. Graduate Institute of Traditional Chinese Medicine, Chang Guang Menorial Hospital, Linkou, Taiwan

Abstract

Abstract Background: Reversal of alcohol-induced peroxisome proliferator-activated receptor (PPAR) α (PPARα) and PPARδ dysfunction has been reported to decrease the severity of alcoholic steatohepatitis (ASH). Autophagy is essential for cell survival and tissue energy homeostasis. Emerging evidence indicates that alcohol-induced adipose tissue (AT) autophagy dysfunction contributes to injury in the intestine, liver, and AT of ASH. Methods: The effects and mechanisms of dual PPARα/δ agonist elafibranor on autophagy stimulation were investigated using mice with ASH. Results: C57BL/6 mice on ethanol diet showed AT dysfunction, disrupted intestinal barrier, and ASH, which was accompanied by alcohol-mediated decrease in PPARα, PPARδ, and autophagy levels in intestine, liver, and AT. Chronic treatment with elafibranor attenuated AT apoptosis and inflammation by restoration of tissue PPARα, PPARδ, and autophagy levels. In ASH mice, alcohol-induced AT dysfunction along with increased fatty acid (FA) uptake and decreased free FA (FFA) release from AT was inhibited by elafibranor. The improvement of AT autophagy dysfunction by elafibranor alleviated inflammation and apoptosis-mediated intestinal epithelial disruption in ASH mice. Acute elafibranor incubation inhibited ethanol-induced ASH-mice-sera-enhanced autophagy dysfunction, apoptosis, barrier disruption, and intracellular steatosis in Caco-2 cells and primary hepatocytes (PHs). Conclusion: Altogether, these findings demonstrated that the PPARα/δ agonist, elafibranor, decreased the severity of liver injury by restoration of alcohol-suppressed AT autophagy function and by decreasing the release of apoptotic markers, inflammatory cytokines, and FFA, thereby reducing intestinal epithelium disruption and liver inflammation/apoptosis/steatosis in ASH mice. These data suggest that dual PPAR agonists can serve as potential therapeutic agents for the management of ASH.

Publisher

Portland Press Ltd.

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3